Recent Advances in Neuroimaging
Article Sidebar
Published:
Feb 18, 2011
Keywords:
Brain imaging Advanced neuroimaging
Main Article Content
Abstract
A huge leap of evolution in neuroimaging has occurred since the invention of magnetic resonance imaging (MRI). In the past, brain imaging with computed tomography (CT) could demonstrate only macro changes of the pathologic lesions. The development of MRI allows us to ‘visualize’ the brain not only as an organ but also at the cellular and molecular level. The developments of biomolecular nanotechnology may help diagnose underlying pathology related biomarkers, for example amyloid plaque in Alzheimer’s disease (AD), or specific neurotransmitters to demon- strate brain images without the necessity for cranial vault opening.
Article Details
How to Cite
1.
Chawalparit O, Tisavipat N. Recent Advances in Neuroimaging. BKK Med J [Internet]. 2011 Feb. 18 [cited 2024 Nov. 23];1(1):85. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/217671
Issue
Section
Reviews Article
This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
1. Kuzniecky R, De La Sayette V, Ethier R, et al. Magnetic resonance imagingintemporallobeepilepsy: pathological correlation. Ann Neurol 1987;22:341-347
2. Pope WB, Sayre J, Perlina A, et al. MR imaging correlates of survival in patients with high-grade gliomas. AJNR 2005;26:2466-2474
3. Young RJ, Knopp EA. Brain MRI: tumor evaluation. J Magn Reson Imaging 2006;24:709-724. DOI:10.1002/ jmri.20704
4. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-798
5. Dong Q, Welsh RC, Chenevert TL, et al. Clinical application of diffusion tensor imaging. J Magn Reson Imaging. 2004;19:6-18
6. Huang W, Roche P, Madajewicz S, et al. Evaluation of brain tumor response to intracarotid chemotherapy using 1H MRS, diffusion, and perfusion MRI(abstract 905) In Proceedings of seventh Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Philadelphia, 1999.
7. Mori S, Frederiksen K, Van Zijl PCM, Stieltjes B, Kraut MA, Slaiyappan M. Et al. Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol 2002;51:377-380
8. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusionsensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrastenhancing tissue. Am J Neuroradiol 2000;21:901-909
9. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility- weighted echo- planar perfusion MR imaging. Radiology 2002;223:11-29
10. Weybright P, Sundgren PC, Maly P, et al. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR 2006;18:1471-1476
11. Haughton VM, Turski PA, Meyerand B, et al. The clinical applications of functional MR imaging. Neuroimaging Clin North Am 1999;9:285-293
12. Chao ST, Suh JH, Raja S, et al. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001;96:191-197
13. Al-Okaili RN, Krejza J, Wang S, et al. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006;26:173-189
14. Rusinek H, De Santi S, Frid D, et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 2003;229:691-696
15. Mathis CA, Wang Y, Holt DP, et al. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothia- zoles as amyloid imaging agents. J Med Chem 2003;46:2740-2754
16. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282: 2003-2011
17. Hacke W, Albers G, Al-Rawi Y, et al. The desmoteplase in acute ischemic stroke trial (DIAS) a phase II MRI based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73
18. Furlan AJ, Eyding D, Albers GW, et al. Dose escalation of desmoteplase for acute ischemic stroke(DEDAS) evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-1231
19. Hoeffner EC, Case I, Jain R, et al. Cerebral perfusion CT: technical applications. Radiology 2004;231:632-644
20. Hoffman JM, Gambhir SS. Molecular imaging: the vision and opportunity for radiology in the future. Radiology 2007;244:39-47
21. Chawalparit O, Artkaew C, Anekthananon T, Tisavipat N, Charnchaowanish P, Sangruchi T. Diagnostic accuracy of perfusion CT in differentiating brain abscess from necrotic tumor. J Med Assoc Thai 2009;92:531-536
22. Coleman MR, Rodd JM, Davis MH, et al. Do vegetative patients retain aspects of language comprehension? Evidence from fMRI. Brain 2007;130:2494-2507
23. Owen AM, Coleman MR, Boly M, et al. Detecting awareness in the vegetative stage. Science 2006;313: 1402
24. Morey RA, Dolcos F, Petty CM, et al. The role of traumatic-related distractors on neural systems for working memory and emotion processing in posttraumatic stress disorder. J Psychiatr Res 2009; 43(8):809
2. Pope WB, Sayre J, Perlina A, et al. MR imaging correlates of survival in patients with high-grade gliomas. AJNR 2005;26:2466-2474
3. Young RJ, Knopp EA. Brain MRI: tumor evaluation. J Magn Reson Imaging 2006;24:709-724. DOI:10.1002/ jmri.20704
4. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-798
5. Dong Q, Welsh RC, Chenevert TL, et al. Clinical application of diffusion tensor imaging. J Magn Reson Imaging. 2004;19:6-18
6. Huang W, Roche P, Madajewicz S, et al. Evaluation of brain tumor response to intracarotid chemotherapy using 1H MRS, diffusion, and perfusion MRI(abstract 905) In Proceedings of seventh Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Philadelphia, 1999.
7. Mori S, Frederiksen K, Van Zijl PCM, Stieltjes B, Kraut MA, Slaiyappan M. Et al. Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol 2002;51:377-380
8. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusionsensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrastenhancing tissue. Am J Neuroradiol 2000;21:901-909
9. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility- weighted echo- planar perfusion MR imaging. Radiology 2002;223:11-29
10. Weybright P, Sundgren PC, Maly P, et al. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR 2006;18:1471-1476
11. Haughton VM, Turski PA, Meyerand B, et al. The clinical applications of functional MR imaging. Neuroimaging Clin North Am 1999;9:285-293
12. Chao ST, Suh JH, Raja S, et al. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001;96:191-197
13. Al-Okaili RN, Krejza J, Wang S, et al. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006;26:173-189
14. Rusinek H, De Santi S, Frid D, et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 2003;229:691-696
15. Mathis CA, Wang Y, Holt DP, et al. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothia- zoles as amyloid imaging agents. J Med Chem 2003;46:2740-2754
16. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282: 2003-2011
17. Hacke W, Albers G, Al-Rawi Y, et al. The desmoteplase in acute ischemic stroke trial (DIAS) a phase II MRI based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73
18. Furlan AJ, Eyding D, Albers GW, et al. Dose escalation of desmoteplase for acute ischemic stroke(DEDAS) evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-1231
19. Hoeffner EC, Case I, Jain R, et al. Cerebral perfusion CT: technical applications. Radiology 2004;231:632-644
20. Hoffman JM, Gambhir SS. Molecular imaging: the vision and opportunity for radiology in the future. Radiology 2007;244:39-47
21. Chawalparit O, Artkaew C, Anekthananon T, Tisavipat N, Charnchaowanish P, Sangruchi T. Diagnostic accuracy of perfusion CT in differentiating brain abscess from necrotic tumor. J Med Assoc Thai 2009;92:531-536
22. Coleman MR, Rodd JM, Davis MH, et al. Do vegetative patients retain aspects of language comprehension? Evidence from fMRI. Brain 2007;130:2494-2507
23. Owen AM, Coleman MR, Boly M, et al. Detecting awareness in the vegetative stage. Science 2006;313: 1402
24. Morey RA, Dolcos F, Petty CM, et al. The role of traumatic-related distractors on neural systems for working memory and emotion processing in posttraumatic stress disorder. J Psychiatr Res 2009; 43(8):809